Clinical Trials Directory

Trials / Completed

CompletedNCT02779335

Enteral Formula Tolerance in Pediatric Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
22 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
1 Year – 13 Years
Healthy volunteers
Not accepted

Summary

The purpose of this prospective study seeks to assess ability to achieve enteral feeding goals with standard polymeric enteral formula in a stable, pediatric tube-fed population.

Detailed description

In this prospective study, a population of stable, tube-fed children will consume a standard polymetric tube feeding formula to assess ability to achieve enteral feeding goals and tolerance outcomes.

Conditions

Interventions

TypeNameDescription
OTHEREnteral Formulapediatric subjects will be fed a standard pediatric enteral formula tube feeding

Timeline

Start date
2016-05-01
Primary completion
2016-10-01
Completion
2016-10-01
First posted
2016-05-20
Last updated
2016-10-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02779335. Inclusion in this directory is not an endorsement.

Enteral Formula Tolerance in Pediatric Patients (NCT02779335) · Clinical Trials Directory